FATE
Fate Therapeutics, Inc.
Set alert
2.08 USD -0.09 -4.15%
2.01 Day range 2.16
0.96 52-week range 3.11
- YTD
- +112.24%
- 1 year
- +61.24%
- Open
- 2.13
- Prev close
- 2.17
- Mkt cap
- 249.23M
- Vol
- 1.06M
- Avg vol
- 1.58M
- EPS
- -1.05
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 2.01
- High
- 2.16
- Forward P/E
- -0.99
- Beta
- 1.88
- Short ratio
- 3.10
- Inst. own
- 102.25%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 2.53
- 200-d avg
- 3.93
- 1y target
- 6.31
1Y chart
Closing price and volume
Compare FATE
Chart and line up FATE against other symbols or a saved comparison set.
- FATE Fate Therapeutics, Inc.
2.08
-0.09 -4.15%
- SPY State Street SPDR S&P 500 ETF Trust
755.72
-13.64 -1.77%
- QQQ Invesco QQQ Trust
690.49
-24.85 -3.47%
Sign in to keep these symbols in a saved comparison set.
| Metric | FATE | SPY | QQQ |
|---|---|---|---|
| Last price | 2.08 | 755.72 | 690.49 |
| Change | -0.09 | -13.64 | -24.85 |
| Change % | -4.15% | -1.77% | -3.47% |
| Open | 2.13 | 761.38 | 697.13 |
| Day high | 2.16 | 761.46 | 698.63 |
| Day low | 2.01 | 750.36 | 683.45 |
| Previous close | 2.17 | 769.36 | 715.34 |
| Volume | 1.06M | 77.70M | 85.24M |
| Average volume | 1.58M | 41.22M | 34.57M |
| Market cap | 249.23M | 812.08B | 483.28B |
| P/E ratio | 0.00 | 23.99 | 26.44 |
| Earnings per share | -1.05 | 31.50 | 26.12 |
| Dividend yield | 0.00 | 0.00 | 0.00 |
| 52-week high | 3.11 | 779.09 | 759.66 |
| 52-week low | 0.96 | 631.97 | 558.28 |
| 1-week return | -1.42% | -0.559233% | -1.97% |
| 1-month return | -12.24% | -0.906075% | -6.66% |
| 3-month return | -17.13% | +1.89% | +1.02% |
| 6-month return | +66.40% | +5.16% | +3.41% |
| Year-to-date return | +112.24% | +10.82% | +12.40% |
| 1-year return | +61.24% | +11.16% | +10.29% |
| 2-year return | -12.24% | +32.90% | +42.71% |
| 50-day moving average | 2.30 | 767.63 | 725.41 |
| 200-day moving average | 1.95 | 728.53 | 679.17 |
| Target price | 6.31 | — | — |
| Beta | 1.88 | 0.00 | 0.00 |
| Short ratio | 3.10 | — | — |
| Institutional ownership | 102.25% | — | — |